Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Opens New East Coast Proteomics Center

NEW YORK, March 14 - Ciphergen Biosystems of Fremont, Calif., said Wednesday it opened a new center in Malvern, Pa., to conduct proteomic research for the company’s customers.

The Biomarker Discovery Center’s first project will entail a clinical stratification pilot study for an unnamed pharmaceutical company. The center will also support the company’s cancer biomarker project with Johns Hopkins School of Medicine. 

"The opening of this center is the next step in our providing advanced proteomics services to our pharmaceutical and biotechnology clients," William Rich, CEO of Ciphergen, said in a statement.

"In particular, we see a major opportunity in using our ProteinChip System to perform differential protein expression analysis to discover biomarkers that may have major applications in pre-clinical and clinical drug development," Rich said.

The ProteinChip System is designed to be used for protein discovery, characterization, and assay development. 

Larry McClain, previously vice president of R&D at Centocor Diagnostics, will manage the new facility, which will also employ two research scientists. 

Separately on Wednesday, Ciphergen’s CEO was named a member of Genomica’s board of directors.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.